AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Thursday, October 15, 2020

In The News

Adopting a more judicious, decision-oriented approach on lab tests for dyslipidemia, the U.S. Departments of Defense (DoD) and Veterans Affairs (VA) are recommending that patients repeat nonfasting lipid profiles just once every 10 years, ceasing any tests once they achieve statin dose goals. DoD and VA also recommend against routine…

AACC Alert

Donor-derived cell-free DNA (dd-cfDNA) is proving its use as a marker of rejection in kidney transplantation. In October’s Clinical Chemistry, a team of researchers determined that absolute dd-cfDNA concentrations is a superior metric to fractional dd-cfDNA (a percentage metric) for surveying grafts in stable transplant patients over a prolonged period…

Inside AACC

A special collections issue from The Journal of Applied Laboratory Medicine brings to light the value of laboratory medicine in the SARS-CoV-2 pandemic, in the opioids epidemic, and in molecular diagnostics. The future of lab medicine will depend more on value basics than testing volume, according to journal Editor-in-Chief Robert…

Practice Management